Deal Corner
February 10, 2024
NDA represents Max Healthcare Institute Limited in its acquisition of Alexis Multi-Speciality Hospital Private Limited

DEAL BRIEF

Max Healthcare Institute Limited (“Max”) has acquired 100% (one hundred percent) equity stake from the promoters in Alexis Multi-Speciality Hospital Private Limited (‘Alexis’) which operates a Nagpur based JCI & NABH accredited 200 bedded hospital namely ‘Alexis Multispecialty Hospital’.

This acquisition further strengthens Max’s footprint in Western India and will enable provisioning of best-in-class clinical care to all patients in the region.

OUR ROLE

We at Nishith Desai Associates conducted due diligence on Alexis and thereafter, acted as the legal and tax advisors to Max for the documentation and the closing of the acquisition.

DEAL TEAM

Nishchal Joshipura

Harshita Srivastava

Chandrashekar K

Ankit Porwal

Anurag Shah

DUE DILIGENCE TEAM

Darren Punnen

Varsha Rajesh

Palomita Sharma

FURTHER DETAILS ARE AVAILABLE AT

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-crore/articleshow/107546548.cms?from=mdr

https://www.financialexpress.com/business/industry-max-healthcare-announces-acquisition-of-100-stake-in-alexis-hospital-for-rs-412-crore-3388979/

https://www.business-standard.com/companies/news/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-cr-124020900635_1.html

 

Disclaimer

The contents of this hotline should not be construed as legal opinion. View detailed disclaimer.

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.

Deal Corner

February 10, 2024

NDA represents Max Healthcare Institute Limited in its acquisition of Alexis Multi-Speciality Hospital Private Limited

DEAL BRIEF

Max Healthcare Institute Limited (“Max”) has acquired 100% (one hundred percent) equity stake from the promoters in Alexis Multi-Speciality Hospital Private Limited (‘Alexis’) which operates a Nagpur based JCI & NABH accredited 200 bedded hospital namely ‘Alexis Multispecialty Hospital’.

This acquisition further strengthens Max’s footprint in Western India and will enable provisioning of best-in-class clinical care to all patients in the region.

OUR ROLE

We at Nishith Desai Associates conducted due diligence on Alexis and thereafter, acted as the legal and tax advisors to Max for the documentation and the closing of the acquisition.

DEAL TEAM

Nishchal Joshipura

Harshita Srivastava

Chandrashekar K

Ankit Porwal

Anurag Shah

DUE DILIGENCE TEAM

Darren Punnen

Varsha Rajesh

Palomita Sharma

FURTHER DETAILS ARE AVAILABLE AT

https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-crore/articleshow/107546548.cms?from=mdr

https://www.financialexpress.com/business/industry-max-healthcare-announces-acquisition-of-100-stake-in-alexis-hospital-for-rs-412-crore-3388979/

https://www.business-standard.com/companies/news/max-healthcare-acquires-nagpur-based-alexis-hospital-for-rs-412-cr-124020900635_1.html

 

Disclaimer

We expressly clarify that this communication is not a solicitation or an invitation of any sort whatsoever from Nishith Desai Associates or any of its members to create an attorney-client relationship. This communication is not intended to be a source of advertising and the recipient should always seek the advice of competent counsel licensed to practice in the recipient's country/state.

This is not a Spam mail. You have received this mail because you have either requested for it or someone must have suggested your name. Since India has no anti-spamming law, we refer to the US directive, which states that a mail cannot be considered Spam if it contains the sender's contact information, which this mail does. In case this mail doesn't concern you, please unsubscribe from mailing list.

NDA Connect

Connect with us at events, 
conferences and seminars.